A Medical Device Daily

Varian (Palo Alto, California) reported a strategic relationship with Drager Safety (Lubeck, Germany) for the distribution of Varian's drugs of abuse testing products (DAT) in North America and Europe.

Drager said the distribution pact is expected to complement its current portfolio of breath alcohol detection products by adding quality DAT products to its screening capability for both alcohol and drugs within the law enforcement and safety environments.

Varian said its On-Site and OnTrak products have pioneered the use of drug screens that deliver rapid, reliable results where and when needed. With a patented design that incorporates unique latex technology, results are available within five minutes – surpassing the industry standard. These drug screens – urine or saliva – are used for pre-employment testing, reasonable cause or incident-driven assessment, routine workplace testing or court-mandated compliance.

In other agreements:

• Nexus Biosystems (Poway, California) reported it has renewed its worldwide marketing agreement with Bruker AXS (Madison, Wisconsin) for Bruker AXS to continue to globally market, sell and support the Nexus Crystal Farm line of products for protein crystallography research.

Nexus Biosystems' Crystal Farm is a line of automated instrumentation products focused on addressing the needs of protein crystallization. At the core of the Crystal Farm is a high resolution imaging system that can “quickly and consistently image hanging, sitting, or micro-batch drops in virtually all plate types,” the company said.

• Osteotech (Eatontown, New Jersey) said that it has entered into an agreement with Premier (San Diego) to provide Premier members its line of products, including Grafton DBM, Graftech Bio-implants and Xpanse Bone Inserts, as well as traditional allograft bone tissue grafts and Osteotech's PEEK-based GraftCage Spacers.

The term of the agreement is for 36 months effective July 1.